|
1
|
de Pauw B: Contemplations on the challenge
of invasive fungal disease. Clin Drug Investig. 33 Suppl 1:S57–S58.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Akan H, Antia VP, Kouba M, Sinkó J, Tănase
AD, Vrhovac R and Herbrecht R: Preventing invasive fungal disease
in patients with haematological malignancies and the recipients of
haematopoietic stem cell transplantation: Practical aspects. J
Antimicrob Chemother. 68 Suppl 3:iii5–iii16. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Drgona L, Colita A, Klimko N, Rahav G,
Ozcan MA and Donnelly JP: Triggers for driving treatment of at-risk
patients with invasive fungal disease. J Antimicrob Chemother. 68
Suppl 3:iii17–iii24. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mikulska M, Furfaro E and Viscoli C:
Non-cultural methods for the diagnosis of invasive fungal disease.
Expert Rev Anti Infect Ther. 13:103–117. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schelenz S, Barnes RA, Barton RC,
Cleverley JR, Lucas SB, Kibbler CC and Denning DW: British Society
for Medical Mycology: British society for medical mycology best
practice recommendations for the diagnosis of serious fungal
diseases. Lancet Infect Dis. 15:461–474. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Desoubeaux G, Bailly É and Chandenier J:
Diagnosis of invasive pulmonary aspergillosis: Updates and
recommendations. Med Mal Infect. 44:89–101. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Powers-Fletcher MV and Hanson KE:
Nonculture diagnostics in fungal disease. Infect Dis Clin North Am.
30:37–49. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cruciani M, Mengoli C, Loeffler J,
Loeffler J, Donnelly P, Barnes R, Jones B, Klingspor L, Morton O
and Maertens J: Polymerase chain reaction blood tests for the
diagnosis of invasive aspergillosis in immunocompromised people.
Cochrane Database Syst Rev: Cd009551. 2015. View Article : Google Scholar
|
|
9
|
Frías-de León MG, Acosta-Altamirano G,
Duarte-Escalante E, Martínez-Hernández JE, Martínez-Rivera Mde L
and Reyes-Montes Mdel R: Molecular markers: An important tool in
the diagnosis, treatment and epidemiology of invasive
aspergillosis. Cir Cir. 82:109–118. 2014.(In Spanish). PubMed/NCBI
|
|
10
|
Halliday CL, Kidd SE, Sorrell TC and Chen
SC: Molecular diagnostic methods for invasive fungal disease: The
horizon draws nearer? Pathology. 47:257–269. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hasseine L, Cassaing S, Robert-Gangneux F,
Fillaux J, Marty P and Gangneux JP: PF-qPCR Study Group: High
negative predictive value diagnostic strategies for the
reevaluation of early antifungal treatment: A multicenter
prospective trial in patients at risk for invasive fungal
infections. J Infect. 71:258–265. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cao G, Zhao Z, Peng Y, Ji Y, Sun J, Wei B
and Liu L: The extraction of fungal genome DNA and the
establishment of a broad-range fungal PCR. Jianyan Yixue.
26:773–778. 2011.(In Chinese).
|
|
13
|
Cao G, Zhao F, Liu Z, Hua L, Ji Y and Zhao
Z: Clinical application of a fungal PCR assay to detect fungal DNA
in sputum specimens. Guoji Jianyan Yixue Zazhi. 33:1635–1636.
2012.(In Chinese).
|
|
14
|
De Pauw B, Walsh TJ, Donnelly JP, Stevens
DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O,
Kauffman CA, et al: Revised definitions of invasive fungal disease
from the European organization for research and treatment of
cancer/invasive fungal infections cooperative group and the
national institute of allergy and infectious diseases mycoses study
group (EORTC/MSG) consensus group. Clin Infect Dis. 46:1813–1821.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
White TJ, Bruns T, Lee S and Taylor JW:
Amplification and direct sequencing of fungal ribosomal RNA genes
for phylogenetics. PCR Protocols. 18:315–322. 1990.
|
|
16
|
Ao JH, Hao ZF, Zhu H, Wen L and Yang RY:
Environmental investigations and molecular typing of
Aspergillus in a Chinese hospital. Mycopathologia.
177:51–57. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jensen L, Jensen AV, Praygod G, Kidola J,
Faurholt-Jepsen D, Changalucha J, Range N, Friis H, Helweg-Larsen
J, Jensen JS and Andersen AB: Infrequent detection of
Pneumocystis jirovecii by PCR in oral wash specimens from TB
patients with or without HIV and healthy contacts in Tanzania. BMC
Infect Dis. 10:1402010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Arishima T and Takezawa J: Use of PCR
based diagnosis for common invasive fungal infections in the
intensive care unit. Nihon Ishinkin Gakkai Zasshi. 47:283–288.
2006.(In Japanese). View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Perfect JR: Fungal diagnosis: How do we do
it and can we do better? Curr Med Res Opin. 29 (Suppl 4):S3–S11.
2013. View Article : Google Scholar
|
|
20
|
Tattevin P, Revest M, Lefort A, Michelet C
and Lortholary O: Fungal endocarditis: Current challenges. Int J
Antimicrob Agents. 44:290–294. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gilchrist KB, Garcia MC, Sobonya R, Lipke
PN and Klotz SA: New features of invasive candidiasis in humans:
Amyloid formation by fungi and deposition of serum amyloid P
component by the host. J Infect Dis. 206:1473–1478. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zeng SY, Liu T, Meng WT and Chen YN: The
significance of serum GM and BG antigens assay for invasive fungal
infections in hematological malignancies patients. Zhonghua Xue Ye
Xue Za Zhi. 32:43–46. 2011.(In Chinese). PubMed/NCBI
|
|
23
|
Ram R, Gafter-Gvili A, Raanani P, Yeshurun
M, Shpilberg O, Dreyer J, Peck A, Leibovici L and Paul M:
Surveillance of infectious complications in hemato-oncological
patients. Isr Med Assoc J. 11:133–137. 2009.PubMed/NCBI
|
|
24
|
Ruhnke M: Antifungal stewardship in
invasive Candida infections. Clin Microbiol Infect. 20
(Suppl 6):S11–S18. 2014. View Article : Google Scholar
|
|
25
|
Kedzierska A, Kochan P, Pietrzyk A and
Kedzierska J: Current status of fungal cell wall components in the
immunodiagnostics of invasive fungal infections in humans:
Galactomannan, mannan and (1->3)-beta-D-glucan antigens. Eur J
Clin Microbiol Infect Dis. 26:755–766. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fortún J, Martín-Dávila P, Alvarez ME,
Norman F, Sánchez-Sousa A, Gajate L, Bárcena R, Nuño SJ and Moreno
S: False-positive results of Aspergillus galactomannan
antigenemia in liver transplant recipients. Transplantation.
87:256–260. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
White PL, Wingard JR, Bretagne S, Löffler
J, Patterson TF, Slavin MA, Barnes RA, Pappas PG and Donnelly JP:
Aspergillus Polymerase Chain reaction: Systematic review of
evidence for clinical use in comparison with antigen testing. Clin
Infect Dis. 61:1293–1303. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sun WK, Zhang F, Xu XY, Shen YY and Shi Y:
A systematic review of the accuracy of diagnostic test of serum
galactomannan antigen detection for invasive aspergillosis.
Zhonghua Jie He He Hu Xi Za Zhi. 33:758–765. 2010.(In Chinese).
PubMed/NCBI
|
|
29
|
Springett GM: Novel pancreatic cancer
vaccines could unleash the army within. Cancer Control. 21:242–246.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jinushi M, Hodi FS and Dranoff G:
Enhancing the clinical activity of granulocyte-macrophage
colony-stimulating factor-secreting tumor cell vaccines. Immunol
Rev. 222:287–298. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dranoff G: GM-CSF-secreting melanoma
vaccines. Oncogene. 22:3188–3192. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bhattacharya S: Early diagnosis of
resistant pathogens: How can it improve antimicrobial treatment?
Virulence. 4:172–184. 2013. View Article : Google Scholar : PubMed/NCBI
|
